Neoadjuvant Treatment in Upper Rectal Cancer Does Not Improve Oncologic Outcomes But Increases Postoperative Morbidity.

导出原文传递

翻译打印收藏纠错

作者： Nicolas,Tabchouri ^[1] ; Yassine,Eid ^[2] ; Gilles,Manceau ^[3] ; Alice,Frontali ^[4] ; Zaher,Lakkis ^[5] ; Ephrem,Salame ^[1] ; Thierry,Lecomte ^[6] ; Sophie,Chapet ^[7] ; Gilles,Calais ^[7] ; Bruno,Heyd ^[5] ; Mehdi,Karoui ^[3] ; Arnaud,Alves ^[2] ; Yves,Panis ^[4] ; Mehdi,Ouaissi ^[8]

作者单位： Department of Digestive, Oncological, Endocrine, Hepato-Biliary, Pancreatic and Liver Transplant Surgery, Trousseau Hospital, Chambray Les Tours, France. ^[1] Service de Chirurgie Digestive, CHU Caen, Université de Caen-Normandie, Caen, France. ^[2] Department of Digestive Surgery, Médecine Sorbonne University, Pitié Salpêtrière University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France. ^[3] Department of Colorectal Surgery, Pôle des Maladies de l'Appareil Digestif (PMAD), Beaujon Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), University Denis Diderot (Paris VII), Clichy, France. ^[4] Department of Digestive Surgery, Besançon University Hospital, Besançon, France. ^[5] Department of Hepatogastroenterology and Digestive Oncology, Trousseau Hospital, Tours, France. ^[6] Department of Radiotherapy, Bretonneau Hospital, Tours, France. ^[7] Department of Digestive, Oncological, Endocrine, Hepato-Biliary, Pancreatic and Liver Transplant Surgery, Trousseau Hospital, Chambray Les Tours, France m.ouaissi@chu-tours.fr. ^[8]

关键词 Upper rectal cancer chemoradiation therapy long-term functional results neoadjuvant treatment recurrence-free and overall survival